Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer

By D’Alessandro R.  

Breast Cancer Research and Treatment, Vol. 68, Iss. 1, 2001-07 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Serum Tumor Marker CA 15.3 and Stage are the Two Most Powerful Predictors of Survival in Primary Breast Cancer

By Kumpulainen E.J.   Keskikuru R.J.   Johansson R.T.  

Breast Cancer Research and Treatment, Vol. 76, Iss. 2, 2002-11 ,pp. : 95-102

Springer Publishing Company

Access to resources Recommend Favorite

Ca 15-3 in the follow-up of localised breast cancer - a prospective study

By Kokko R.   Holli K.   Hakama M.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1189-1193

Elsevier

Access to resources Recommend Favorite

CSF CA 15-3 in breast cancer-related leptomeningeal metastases

By Le Rhun Emilie   Kramar Andrew   Salingue Sophie   Girot Marie   Rodrigues Isabelle   Mailliez Audrey   Zairi Fahed   Bakhache Edgar   Robin Yves   Taillibert Sophie   Dubois François   Bonneterre Jacques   Chamberlain Marc  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 117-124

Springer Publishing Company

Access to resources Recommend Favorite

CA27.29 - a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases

By Gion M.   Mione R.   Leon A.E.   Luftner D.   Molina R.   Possinger K.   Robertson J.F.  

European Journal of Cancer, Vol. 37, Iss. 3, 2001-02 ,pp. : 355-363

Elsevier

Access to resources Recommend Favorite